Members of the Board of Directors
Members of the Board of Directors
René Branchaud – Chairman of the Board & Corporate Secretary
René Branchaud has been practicing law since 1983. He is a partner with the law firm Lavery, de Billy and practices in the areas of securities law, mergers and acquisitions and corporate law. He assists companies in connection with their incorporation, corporate structure, shareholders’ agreements, private placements, public offerings, stock exchange listings as well as dispositions and takeovers.
He is also on the Board of Directors of several public corporations and also site on the Board of Directors of several public corporations and also serves on several committees of the board of directors, including corporate governance committees and ad hoc committees created for specific transactions (mergers, takeovers). In addition, he advises directors who sit on ad hoc committees.
Mr. Mokaddem has held senior positions at YNNA Holding, ONA Group and OCP Group. He has played an important role in the development of several major mining operations, such as the Akka gold mine and the Guemassa complex in Morocco. Mr. Mokaddem holds a bachelor’s degree in Engineering from the State School of Engineers, in Mons, Belgium.
Mr. Taub holds a BA in Languages from the University of Antwerp (Belgium) and an MBA from INSEAD (Fontainebleau, France). He is an entrepreneur in the Life Science field and investor in several pharmaceutical and medical device companies. Mr. Taub was the CEO of a NASDAQ listed company which he had founded and is currently an investor and Chairman of another NASDAQ company.
Mr. Sofronis is Director of Irini Investment of Luxembourg and has over 18 years of private equity experience in mining and biotechnology sectors.
Eric Swenden, MCS Director(independent)
Mr. Swenden has had a long and successful career in finance and company management and has held various senior positions in companies, including Vandemoortele Food Group, General Bank (Fortis) and Besix. He serves as member of the board of directors for various companies, including Lifeline Scientific and Redhill Biopharma.
Mr. Wong is a seasoned financier and a member of the Ordre des comptables agréés du Québec. He has been involved in auditing, tax planning and debt restructuring and the right-sizing of operating companies in the resource, manufacturing, consumer product, and life science industries.
For the last five years, he has acted as an independent capital markets advisor to public companies as well as the Executive Chairman of a biotech research and product development company, in support of translational immunology research in oncology, neuroscience and microbiology.
Before that, Mr. Wong was with Dundee Securities Corporation’s Investment Banking group, where he structured, developed and completed a range of capital market transactions, including public offerings, capital market equity issues, and merger and acquisitions. He provided financial advisory services to the resource (mining and oil) industry, airlines, and real estate entities. He has been on both the buy and sell side of the investment industry. Martin’s recent accomplishments include IPOs of mining companies, and treasury equity issues of Canadian listed companies, the development of takeover defense strategies, acquisitions and capital market advisory mandates.
Mr. Wong a co-founder and managing partner at Milton Capital Partners Limited a capital markets boutique advisor, is a CPA CA and is accredited in real estate finance from UBC.
(2) Compensation Committee member
(3) Corporate Governance Committee member
(4) Environmental, Health and Safety and Sustainability